{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T14:22:55Z","timestamp":1788790975340,"version":"build-2803163510"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>Atopic dermatitis is a chronic, systemic disease with primary cutaneous clinical manifestations and is commonly attributed to an exaggerated Th2 inflammatory response. Recent research regarding risk factors, prevention, clinical features, and management of atopic dermatitis will be reviewed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>In the last decade, advances have been made in identifying the factors that either confer increased risk for or protection from atopic dermatitis and associated atopy. Progress has also been made in the clinical management of this disease. Promising biomarkers and therapeutically informative characteristics of this disease have been identified in young children with and without the presence of eczema, but much has yet to be elucidated. Progress has also been made in clarifying the advantages and disadvantages of respective medical managements, including but not limited to topical corticosteroids, topical calcineurin inhibitors, phototherapy, systemic immunosuppressants, and targeted immunotherapy. Given that medical management may show variable efficacy in a child, an optimized skin care regimen is of utmost importance as well.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Atopic dermatitis is a challenging, chronic systemic disease that incurs significant morbidity in affected children. Although management options have been somewhat disappointing in years past, promising results have been observed in recent advances in targeted immunotherapy.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mop.0000000000001293","type":"journal-article","created":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T04:02:13Z","timestamp":1696219333000},"page":"686-691","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["A practical approach to caring for atopic dermatitis in children"],"prefix":"10.1097","volume":"35","author":[{"given":"Diana K.","family":"Bayer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,9,29]]},"reference":[{"key":"R1-20250730","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jaip.2022.10.032","article-title":"Patients\u2019 and caregivers\u2019 experiences with atopic dermatitis-related burden, medical care, and treatments in 8 countries","volume":"11","author":"Capozza","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R2-20250730","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jaip.2022.09.021","article-title":"Impact of a decade of research into atopic dermatitis","volume":"11","author":"Arkwright","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R3-20250730","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.jaci.2023.02.013","article-title":"Stratum corneum lipid and cytokine biomarkers at age 2\u200amonths predict the future onset of atopic dermatitis","volume":"151","author":"Berdyshev","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"R4-20250730","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.jaip.2023.02.005","article-title":"Targeting skin barrier function in atopic dermatitis","volume":"11","author":"van den Bogaard","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R5-20250730","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jaci.2022.07.021","article-title":"Endotypes of atopic dermatitis and food allergy","volume":"151","author":"Hui-Beckman","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"R6-20250730","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1016\/j.jaci.2021.09.036","article-title":"Longitudinal atopic dermatitis endotypes: an atopic march paradigm that includes Black children","volume":"149","author":"Biagini","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"R7-20250730","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1016\/j.jaip.2022.06.038","article-title":"Current use of probiotics and prebiotics in allergy","volume":"10","author":"Fiocchi","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R8-20250730","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.det.2021.12.002","article-title":"Evolving landscape of systemic therapy for pediatric atopic dermatitis","volume":"40","author":"Lockhart","year":"2022","journal-title":"Dermatol Clin"},{"key":"R9-20250730","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.jaip.2023.03.041","article-title":"Managing atopic dermatitis in patients with skin of color","volume":"11","author":"Davis","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R10-20250730","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/j.jaip.2022.04.001","article-title":"Atopy as immune dysregulation: offender genes and targets","volume":"10","author":"Vaseghi-Shanjani","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R11-20250730","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.jaip.2022.02.016","article-title":"Eosinophilia associated with immune deficiency","volume":"10","author":"Olbrich","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R12-20250730","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S2352-4642(22)00146-8","article-title":"Effectiveness and safety of lotion, cream, gel, and ointment emollients for childhood eczema: a pragmatic, randomised, phase 4, superiority trial","volume":"6","author":"Ridd","year":"2022","journal-title":"Lancet Child Adolesc Health"},{"key":"R13-20250730","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jaad.2022.04.034","article-title":"Allergens and marketing claims of the most popular baby moisturizers: a product analysis","volume":"88","author":"Rick","year":"2023","journal-title":"J Am Acad Dermatol"},{"key":"R14-20250730","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.jaip.2023.01.012","article-title":"Skin antiseptics for atopic dermatitis: dissecting facts from fiction","volume":"11","author":"Ong","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R15-20250730","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.anai.2022.03.024","article-title":"Bleach baths for atopic dermatitis: a systematic review and meta-analysis including unpublished data, Bayesian interpretation, and GRADE","volume":"128","author":"Bakaa","year":"2022","journal-title":"Ann Allergy Asthma Immunol"},{"key":"R16-20250730","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1016\/j.jaip.2022.06.044","article-title":"Dietary elimination for the treatment of atopic dermatitis: a systematic review and meta-analysis","volume":"10","author":"Oykhman","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R17-20250730","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1016\/j.jaip.2022.05.028","article-title":"Prevalence of food allergy diagnosis in pediatric patients with atopic dermatitis referred to allergy and\/or dermatology subspecialty clinics","volume":"10","author":"Li","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R18-20250730","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.jaip.2021.12.037","article-title":"Atopic dermatitis and food allergy: best practices and knowledge gaps \u2013 a work group report from the AAAAI Allergic Skin Diseases Committee and Leadership Institute Project","volume":"10","author":"Singh","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R19-20250730","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/pde.15143","article-title":"The effect of fatty acids, vitamins, and minerals on pediatric atopic dermatitis: a systematic review","volume":"40","author":"Labib","year":"2023","journal-title":"Pediatr Dermatol"},{"key":"R20-20250730","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.jaip.2023.03.022","article-title":"A Comparison of topical corticosteroids and topical calcineurin inhibitors for the treatment of atopic dermatitis","volume":"11","author":"Pena","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R21-20250730","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.anai.2017.10.039","article-title":"Atopic dermatitis yardstick: practical recommendations for an evolving therapeutic landscape","volume":"120","author":"Boguniewicz","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"R22-20250730","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.jaci.2023.01.001","article-title":"Might biologics serve to interrupt the atopic march?","volume":"151","author":"Spergel","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"R23-20250730","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.jaip.2023.03.020","article-title":"Dupilumab inhibits vascular leakage of blood proteins into atopic dermatitis skin","volume":"11","author":"Leung","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R24-20250730","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.jaci.2022.11.019","article-title":"Host-microbiome interactions in the holobiome of atopic dermatitis","volume":"151","author":"Burger","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"R25-20250730","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/pde.14909","article-title":"Infections in children and adolescents treated with dupilumab in pediatric clinical trials for atopic dermatitis \u2013 a pooled analysis of trial data","volume":"39","author":"Paller","year":"2022","journal-title":"Pediatr Dermatol"},{"key":"R26-20250730","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.jaip.2022.02.026","article-title":"Dupilumab demonstrates rapid onset of response across three type 2 inflammatory diseases","volume":"10","author":"Canonica","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R27-20250730","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1016\/j.jaip.2022.06.014","article-title":"Dupilumab improves clinical scores in children and adolescents with moderate to severe atopic dermatitis: a real-world, single-center study","volume":"10","author":"Pagan","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R28-20250730","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.jaip.2023.03.023","article-title":"Challenging best practice of atopic dermatitis","volume":"11","author":"Arkwright","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R29-20250730","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.jaci.2022.08.026","article-title":"Attenuating the atopic march: meta-analysis of the dupilumab atopic dermatitis database for incident allergic events","volume":"151","author":"Geba","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"R30-20250730","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.jaip.2023.03.011","article-title":"Biologic versus small molecule therapy for treating moderate to severe atopic dermatitis: clinical considerations","volume":"11","author":"Butala","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R31-20250730","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.acap.2021.07.008","article-title":"Management of pediatric atopic dermatitis by primary care providers: a systematic review","volume":"21","author":"Young","year":"2021","journal-title":"Acad Pediatr"},{"key":"R32-20250730","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.anai.2023.03.010","article-title":"Atopic dermatitis yardstick update","volume":"130","author":"Boguniewicz","year":"2023","journal-title":"Ann Allergy Asthma Immunol"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000001293","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T18:00:51Z","timestamp":1753898451000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000001293"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,29]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0000000000001293","relation":{},"ISSN":["1040-8703","1531-698X"],"issn-type":[{"value":"1040-8703","type":"print"},{"value":"1531-698X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,29]]}}}